arrow
M

Mengru Chang

ludong university
H指数:6
被引数:318

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2

ZUMA-2接受anti-CD19 car-t细胞治疗的复发/难治性套细胞淋巴瘤患者的五年随访,队列1和2

2026-04-270
OAAI
Five-Year Outcomes of Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Treated with Brexucabtagene Autoleucel (Brexu-cel) in ZUMA-2 Cohorts 1 and 2

ZUMA-2研究队列1和2中接受Brexucabtagene autoleucel(Brexu-cel)治疗的复发/难治性套细胞淋巴瘤(R/R MCL)患者的五年结局

BLOOD
IF23.1
2024-11-050
PRE